Penile cancer and lymph node management: a call for standardization
- PMID: 41258991
- DOI: 10.1007/s11255-025-04911-6
Penile cancer and lymph node management: a call for standardization
Abstract
Purpose: This study aims to compare and organize recommendations from the most eminent international guidelines on the staging and treatment of lymph node (LN) involvement in penile cancer (PC). Early recognition and appropriate management of nodal disease remain the cornerstone of care, influencing both survival and treatment-related morbidity.
Methods: This study compares and organize recommendations form the most eminent international guidelines-including NCCN, ESMO-EURACAN, and EAU-ASCO-on the staging and treatment of lymph node involvement in penile cancer.
Results: Open inguinal LN dissection (ILND) remains the standard treatment for not superficial cancers and its morbidity has driven interest in minimally invasive surgical approaches, such as video-endoscopic inguinal lymphadenectomy (VEIL), including its robot-assisted variant (RA-VEIL). Their role is well defined in clinically node-negative (cN0) patients but remains investigational in node-positive (cN+) cases. For cN3 disease and pelvic node involvement, multimodal strategies including chemotherapy, surgery, and radiotherapy are required.
Conclusion: The variability among guidelines underscores the need for collaborative efforts and high-quality prospective trials to refine and standardize treatment recommendations.
Keywords: Inguinal lymph node dissection; Lymph node management; Penile cancer; penile cancer guidelines.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
References
-
- Fu L, Tian T, Yao K, Chen XF, Luo G, Gao Y, Lin Y-F, Wang B, Sun Y, Zheng W, Li P, Zhan Y, Fairley CK, Grulich A, Zou H (2022) Global pattern and trends in penile cancer incidence: population-based study. JMIR Public Health Surveill 8(7):e34874. https://doi.org/10.2196/34874 - DOI - PubMed - PMC
-
- Passaro F, Tufano A, Spena G, Izzo A, Scarlata FA, Barone B, Napolitano L, Pezone G, Alvino P, Aveta A, Pandolfo SD, Cilio S, Romano L, Di Bello F, Calarco A, Leonardi R, Buonerba C, Perdonà S (2025) Preoperative platelet-to-lymphocyte ratio as a predictor of inguinal lymph node metastasis in penile cancer. Arch Ital Urol Androl 97(1):13428. https://doi.org/10.4081/aiua.2025.13428 - DOI - PubMed
-
- Ravi R (1993) Morbidity following groin dissection for penile carcinoma. Br J Urol 72(6):941–945. https://doi.org/10.1111/j.1464-410X.1993.tb16304.x - DOI - PubMed
-
- Brouwer OR, Albersen M, Parnham A, Protzel C, Pettaway CA, Ayres B, Antunes-Lopes T, Barreto L, Campi R, Crook J, Fernández-Pello S, Greco I, van der Heijden MS, Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Garcia-Perdomo HA, Rumble RB, Sachdeva A, Sakalis VI, Zapala Ł, Sánchez Martínez DF, Spiess PE, Tagawa ST (2023) European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 update. Eur Urol 83(6):548–560. https://doi.org/10.1016/j.eururo.2023.02.027 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
